img

Global Human Interleukin-2 for Injection Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Interleukin-2 for Injection Market Insights, Forecast to 2034

Interleukin-2 is ia type of medication called a biologic response modifier. It is a type of protein called a cytokine that works to increase the production and function of some parts of your body's immune system.
Global Human Interleukin-2 for Injection market is expected to reach to US$ 45 million in 2024, with a positive growth of %, compared with US$ 43 million in 2022. Backed with the increasing demand from downstream industries, Human Interleukin-2 for Injection industry is evaluated to reach US$ 59 million in 2029. The CAGR will be 4.5% during 2024 to 2029.
Human Interleukin-2 (IL-2) is a vital immunoregulatory protein used in the treatment of various cancers and immune-related diseases. The market is substantial and continuously expanding, benefiting from the growing population of cancer patients and the widespread application of immunotherapy. Sales are consistently rising, especially in novel immunotherapy fields like CAR-T cell therapy. Specific uses include the treatment of malignancies such as malignant melanoma, renal cell carcinoma, and advanced metastatic colorectal cancer. The future development prospects are promising, with anticipated approvals for more indications and treatment modalities driving continued market growth.
Report Covers
This report presents an overview of global Human Interleukin-2 for Injection market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Human Interleukin-2 for Injection market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Clinigen
3SBio
Beijing Four Rings Biopharmaceutical
Jiangsu Kingsley Pharmaceutical
Beijing Yuance Pharmaceutical
Beijing SL Pharm
Shanghai Huaxin Biotechnology
Changchun Institute Of Biological Products
Shandong Quangang Pharmaceutical
Segment by Type
50000 IU
100000 IU
200000 IU
500000 IU
1 Million IU

Segment by Application


Hospital
Pharmacy

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Human Interleukin-2 for Injection plant distribution, commercial date of Human Interleukin-2 for Injection, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Human Interleukin-2 for Injection introduction, etc. Human Interleukin-2 for Injection Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Human Interleukin-2 for Injection
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Human Interleukin-2 for Injection Product Introduction
1.2 Market by Type
1.2.1 Global Human Interleukin-2 for Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 50000 IU
1.2.3 100000 IU
1.2.4 200000 IU
1.2.5 500000 IU
1.2.6 1 Million IU
1.3 Market by Application
1.3.1 Global Human Interleukin-2 for Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Interleukin-2 for Injection Sales Estimates and Forecasts 2018-2029
2.2 Global Human Interleukin-2 for Injection Revenue by Region
2.2.1 Global Human Interleukin-2 for Injection Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Human Interleukin-2 for Injection Revenue by Region (2018-2024)
2.2.3 Global Human Interleukin-2 for Injection Revenue by Region (2024-2029)
2.2.4 Global Human Interleukin-2 for Injection Revenue Market Share by Region (2018-2029)
2.3 Global Human Interleukin-2 for Injection Sales Estimates and Forecasts 2018-2029
2.4 Global Human Interleukin-2 for Injection Sales by Region
2.4.1 Global Human Interleukin-2 for Injection Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Human Interleukin-2 for Injection Sales by Region (2018-2024)
2.4.3 Global Human Interleukin-2 for Injection Sales by Region (2024-2029)
2.4.4 Global Human Interleukin-2 for Injection Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Human Interleukin-2 for Injection Sales by Manufacturers
3.1.1 Global Human Interleukin-2 for Injection Sales by Manufacturers (2018-2024)
3.1.2 Global Human Interleukin-2 for Injection Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Interleukin-2 for Injection in 2022
3.2 Global Human Interleukin-2 for Injection Revenue by Manufacturers
3.2.1 Global Human Interleukin-2 for Injection Revenue by Manufacturers (2018-2024)
3.2.2 Global Human Interleukin-2 for Injection Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Human Interleukin-2 for Injection Revenue in 2022
3.3 Global Key Players of Human Interleukin-2 for Injection, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Human Interleukin-2 for Injection Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Interleukin-2 for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Interleukin-2 for Injection, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Interleukin-2 for Injection, Product Offered and Application
3.8 Global Key Manufacturers of Human Interleukin-2 for Injection, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Interleukin-2 for Injection Sales by Type
4.1.1 Global Human Interleukin-2 for Injection Historical Sales by Type (2018-2024)
4.1.2 Global Human Interleukin-2 for Injection Forecasted Sales by Type (2024-2029)
4.1.3 Global Human Interleukin-2 for Injection Sales Market Share by Type (2018-2029)
4.2 Global Human Interleukin-2 for Injection Revenue by Type
4.2.1 Global Human Interleukin-2 for Injection Historical Revenue by Type (2018-2024)
4.2.2 Global Human Interleukin-2 for Injection Forecasted Revenue by Type (2024-2029)
4.2.3 Global Human Interleukin-2 for Injection Revenue Market Share by Type (2018-2029)
4.3 Global Human Interleukin-2 for Injection Price by Type
4.3.1 Global Human Interleukin-2 for Injection Price by Type (2018-2024)
4.3.2 Global Human Interleukin-2 for Injection Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Human Interleukin-2 for Injection Sales by Application
5.1.1 Global Human Interleukin-2 for Injection Historical Sales by Application (2018-2024)
5.1.2 Global Human Interleukin-2 for Injection Forecasted Sales by Application (2024-2029)
5.1.3 Global Human Interleukin-2 for Injection Sales Market Share by Application (2018-2029)
5.2 Global Human Interleukin-2 for Injection Revenue by Application
5.2.1 Global Human Interleukin-2 for Injection Historical Revenue by Application (2018-2024)
5.2.2 Global Human Interleukin-2 for Injection Forecasted Revenue by Application (2024-2029)
5.2.3 Global Human Interleukin-2 for Injection Revenue Market Share by Application (2018-2029)
5.3 Global Human Interleukin-2 for Injection Price by Application
5.3.1 Global Human Interleukin-2 for Injection Price by Application (2018-2024)
5.3.2 Global Human Interleukin-2 for Injection Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Human Interleukin-2 for Injection Market Size by Type
6.1.1 US & Canada Human Interleukin-2 for Injection Sales by Type (2018-2029)
6.1.2 US & Canada Human Interleukin-2 for Injection Revenue by Type (2018-2029)
6.2 US & Canada Human Interleukin-2 for Injection Market Size by Application
6.2.1 US & Canada Human Interleukin-2 for Injection Sales by Application (2018-2029)
6.2.2 US & Canada Human Interleukin-2 for Injection Revenue by Application (2018-2029)
6.3 US & Canada Human Interleukin-2 for Injection Market Size by Country
6.3.1 US & Canada Human Interleukin-2 for Injection Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Human Interleukin-2 for Injection Sales by Country (2018-2029)
6.3.3 US & Canada Human Interleukin-2 for Injection Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Human Interleukin-2 for Injection Market Size by Type
7.1.1 Europe Human Interleukin-2 for Injection Sales by Type (2018-2029)
7.1.2 Europe Human Interleukin-2 for Injection Revenue by Type (2018-2029)
7.2 Europe Human Interleukin-2 for Injection Market Size by Application
7.2.1 Europe Human Interleukin-2 for Injection Sales by Application (2018-2029)
7.2.2 Europe Human Interleukin-2 for Injection Revenue by Application (2018-2029)
7.3 Europe Human Interleukin-2 for Injection Market Size by Country
7.3.1 Europe Human Interleukin-2 for Injection Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Human Interleukin-2 for Injection Sales by Country (2018-2029)
7.3.3 Europe Human Interleukin-2 for Injection Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Human Interleukin-2 for Injection Market Size
8.1.1 China Human Interleukin-2 for Injection Sales (2018-2029)
8.1.2 China Human Interleukin-2 for Injection Revenue (2018-2029)
8.2 China Human Interleukin-2 for Injection Market Size by Application
8.2.1 China Human Interleukin-2 for Injection Sales by Application (2018-2029)
8.2.2 China Human Interleukin-2 for Injection Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Human Interleukin-2 for Injection Market Size by Type
9.1.1 Asia Human Interleukin-2 for Injection Sales by Type (2018-2029)
9.1.2 Asia Human Interleukin-2 for Injection Revenue by Type (2018-2029)
9.2 Asia Human Interleukin-2 for Injection Market Size by Application
9.2.1 Asia Human Interleukin-2 for Injection Sales by Application (2018-2029)
9.2.2 Asia Human Interleukin-2 for Injection Revenue by Application (2018-2029)
9.3 Asia Human Interleukin-2 for Injection Sales by Region
9.3.1 Asia Human Interleukin-2 for Injection Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Human Interleukin-2 for Injection Revenue by Region (2018-2029)
9.3.3 Asia Human Interleukin-2 for Injection Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Interleukin-2 for Injection Market Size by Type
10.1.1 Middle East, Africa and Latin America Human Interleukin-2 for Injection Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Human Interleukin-2 for Injection Market Size by Application
10.2.1 Middle East, Africa and Latin America Human Interleukin-2 for Injection Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Human Interleukin-2 for Injection Sales by Country
10.3.1 Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Human Interleukin-2 for Injection Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Clinigen
11.1.1 Clinigen Company Information
11.1.2 Clinigen Overview
11.1.3 Clinigen Human Interleukin-2 for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Clinigen Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Clinigen Recent Developments
11.2 3SBio
11.2.1 3SBio Company Information
11.2.2 3SBio Overview
11.2.3 3SBio Human Interleukin-2 for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 3SBio Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 3SBio Recent Developments
11.3 Beijing Four Rings Biopharmaceutical
11.3.1 Beijing Four Rings Biopharmaceutical Company Information
11.3.2 Beijing Four Rings Biopharmaceutical Overview
11.3.3 Beijing Four Rings Biopharmaceutical Human Interleukin-2 for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Beijing Four Rings Biopharmaceutical Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Beijing Four Rings Biopharmaceutical Recent Developments
11.4 Jiangsu Kingsley Pharmaceutical
11.4.1 Jiangsu Kingsley Pharmaceutical Company Information
11.4.2 Jiangsu Kingsley Pharmaceutical Overview
11.4.3 Jiangsu Kingsley Pharmaceutical Human Interleukin-2 for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Jiangsu Kingsley Pharmaceutical Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Jiangsu Kingsley Pharmaceutical Recent Developments
11.5 Beijing Yuance Pharmaceutical
11.5.1 Beijing Yuance Pharmaceutical Company Information
11.5.2 Beijing Yuance Pharmaceutical Overview
11.5.3 Beijing Yuance Pharmaceutical Human Interleukin-2 for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Beijing Yuance Pharmaceutical Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Beijing Yuance Pharmaceutical Recent Developments
11.6 Beijing SL Pharm
11.6.1 Beijing SL Pharm Company Information
11.6.2 Beijing SL Pharm Overview
11.6.3 Beijing SL Pharm Human Interleukin-2 for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Beijing SL Pharm Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Beijing SL Pharm Recent Developments
11.7 Shanghai Huaxin Biotechnology
11.7.1 Shanghai Huaxin Biotechnology Company Information
11.7.2 Shanghai Huaxin Biotechnology Overview
11.7.3 Shanghai Huaxin Biotechnology Human Interleukin-2 for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Shanghai Huaxin Biotechnology Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Shanghai Huaxin Biotechnology Recent Developments
11.8 Changchun Institute Of Biological Products
11.8.1 Changchun Institute Of Biological Products Company Information
11.8.2 Changchun Institute Of Biological Products Overview
11.8.3 Changchun Institute Of Biological Products Human Interleukin-2 for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Changchun Institute Of Biological Products Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Changchun Institute Of Biological Products Recent Developments
11.9 Shandong Quangang Pharmaceutical
11.9.1 Shandong Quangang Pharmaceutical Company Information
11.9.2 Shandong Quangang Pharmaceutical Overview
11.9.3 Shandong Quangang Pharmaceutical Human Interleukin-2 for Injection Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Shandong Quangang Pharmaceutical Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Shandong Quangang Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Interleukin-2 for Injection Industry Chain Analysis
12.2 Human Interleukin-2 for Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Interleukin-2 for Injection Production Mode & Process
12.4 Human Interleukin-2 for Injection Sales and Marketing
12.4.1 Human Interleukin-2 for Injection Sales Channels
12.4.2 Human Interleukin-2 for Injection Distributors
12.5 Human Interleukin-2 for Injection Customers
13 Market Dynamics
13.1 Human Interleukin-2 for Injection Industry Trends
13.2 Human Interleukin-2 for Injection Market Drivers
13.3 Human Interleukin-2 for Injection Market Challenges
13.4 Human Interleukin-2 for Injection Market Restraints
14 Key Findings in The Global Human Interleukin-2 for Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Interleukin-2 for Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 50000 IU
Table 3. Major Manufacturers of 100000 IU
Table 4. Major Manufacturers of 200000 IU
Table 5. Major Manufacturers of 500000 IU
Table 6. Major Manufacturers of 1 Million IU
Table 7. Global Human Interleukin-2 for Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Human Interleukin-2 for Injection Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Human Interleukin-2 for Injection Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Human Interleukin-2 for Injection Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Human Interleukin-2 for Injection Revenue Market Share by Region (2018-2024)
Table 12. Global Human Interleukin-2 for Injection Revenue Market Share by Region (2024-2029)
Table 13. Global Human Interleukin-2 for Injection Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Human Interleukin-2 for Injection Sales by Region (2018-2024) & (K Units)
Table 15. Global Human Interleukin-2 for Injection Sales by Region (2024-2029) & (K Units)
Table 16. Global Human Interleukin-2 for Injection Sales Market Share by Region (2018-2024)
Table 17. Global Human Interleukin-2 for Injection Sales Market Share by Region (2024-2029)
Table 18. Global Human Interleukin-2 for Injection Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global Human Interleukin-2 for Injection Sales Share by Manufacturers (2018-2024)
Table 20. Global Human Interleukin-2 for Injection Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Human Interleukin-2 for Injection Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Human Interleukin-2 for Injection, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Human Interleukin-2 for Injection Price by Manufacturers 2018-2024 (US$/Unit)
Table 24. Global Human Interleukin-2 for Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Human Interleukin-2 for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Interleukin-2 for Injection as of 2022)
Table 26. Global Key Manufacturers of Human Interleukin-2 for Injection, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Human Interleukin-2 for Injection, Product Offered and Application
Table 28. Global Key Manufacturers of Human Interleukin-2 for Injection, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Human Interleukin-2 for Injection Sales by Type (2018-2024) & (K Units)
Table 31. Global Human Interleukin-2 for Injection Sales by Type (2024-2029) & (K Units)
Table 32. Global Human Interleukin-2 for Injection Sales Share by Type (2018-2024)
Table 33. Global Human Interleukin-2 for Injection Sales Share by Type (2024-2029)
Table 34. Global Human Interleukin-2 for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Human Interleukin-2 for Injection Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Human Interleukin-2 for Injection Revenue Share by Type (2018-2024)
Table 37. Global Human Interleukin-2 for Injection Revenue Share by Type (2024-2029)
Table 38. Human Interleukin-2 for Injection Price by Type (2018-2024) & (US$/Unit)
Table 39. Global Human Interleukin-2 for Injection Price Forecast by Type (2024-2029) & (US$/Unit)
Table 40. Global Human Interleukin-2 for Injection Sales by Application (2018-2024) & (K Units)
Table 41. Global Human Interleukin-2 for Injection Sales by Application (2024-2029) & (K Units)
Table 42. Global Human Interleukin-2 for Injection Sales Share by Application (2018-2024)
Table 43. Global Human Interleukin-2 for Injection Sales Share by Application (2024-2029)
Table 44. Global Human Interleukin-2 for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Human Interleukin-2 for Injection Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Human Interleukin-2 for Injection Revenue Share by Application (2018-2024)
Table 47. Global Human Interleukin-2 for Injection Revenue Share by Application (2024-2029)
Table 48. Human Interleukin-2 for Injection Price by Application (2018-2024) & (US$/Unit)
Table 49. Global Human Interleukin-2 for Injection Price Forecast by Application (2024-2029) & (US$/Unit)
Table 50. US & Canada Human Interleukin-2 for Injection Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada Human Interleukin-2 for Injection Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Human Interleukin-2 for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Human Interleukin-2 for Injection Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Human Interleukin-2 for Injection Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada Human Interleukin-2 for Injection Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Human Interleukin-2 for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Human Interleukin-2 for Injection Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Human Interleukin-2 for Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Human Interleukin-2 for Injection Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Human Interleukin-2 for Injection Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Human Interleukin-2 for Injection Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada Human Interleukin-2 for Injection Sales by Country (2024-2029) & (K Units)
Table 63. Europe Human Interleukin-2 for Injection Sales by Type (2018-2024) & (K Units)
Table 64. Europe Human Interleukin-2 for Injection Sales by Type (2024-2029) & (K Units)
Table 65. Europe Human Interleukin-2 for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Human Interleukin-2 for Injection Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Human Interleukin-2 for Injection Sales by Application (2018-2024) & (K Units)
Table 68. Europe Human Interleukin-2 for Injection Sales by Application (2024-2029) & (K Units)
Table 69. Europe Human Interleukin-2 for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Human Interleukin-2 for Injection Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Human Interleukin-2 for Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Human Interleukin-2 for Injection Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Human Interleukin-2 for Injection Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Human Interleukin-2 for Injection Sales by Country (2018-2024) & (K Units)
Table 75. Europe Human Interleukin-2 for Injection Sales by Country (2024-2029) & (K Units)
Table 76. China Human Interleukin-2 for Injection Sales by Type (2018-2024) & (K Units)
Table 77. China Human Interleukin-2 for Injection Sales by Type (2024-2029) & (K Units)
Table 78. China Human Interleukin-2 for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Human Interleukin-2 for Injection Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Human Interleukin-2 for Injection Sales by Application (2018-2024) & (K Units)
Table 81. China Human Interleukin-2 for Injection Sales by Application (2024-2029) & (K Units)
Table 82. China Human Interleukin-2 for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Human Interleukin-2 for Injection Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Human Interleukin-2 for Injection Sales by Type (2018-2024) & (K Units)
Table 85. Asia Human Interleukin-2 for Injection Sales by Type (2024-2029) & (K Units)
Table 86. Asia Human Interleukin-2 for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Human Interleukin-2 for Injection Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Human Interleukin-2 for Injection Sales by Application (2018-2024) & (K Units)
Table 89. Asia Human Interleukin-2 for Injection Sales by Application (2024-2029) & (K Units)
Table 90. Asia Human Interleukin-2 for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Human Interleukin-2 for Injection Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Human Interleukin-2 for Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Human Interleukin-2 for Injection Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Human Interleukin-2 for Injection Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Human Interleukin-2 for Injection Sales by Region (2018-2024) & (K Units)
Table 96. Asia Human Interleukin-2 for Injection Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Human Interleukin-2 for Injection Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Human Interleukin-2 for Injection Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Human Interleukin-2 for Injection Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Human Interleukin-2 for Injection Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Human Interleukin-2 for Injection Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Human Interleukin-2 for Injection Sales by Country (2024-2029) & (K Units)
Table 110. Clinigen Company Information
Table 111. Clinigen Description and Major Businesses
Table 112. Clinigen Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Clinigen Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Clinigen Recent Developments
Table 115. 3SBio Company Information
Table 116. 3SBio Description and Major Businesses
Table 117. 3SBio Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. 3SBio Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. 3SBio Recent Developments
Table 120. Beijing Four Rings Biopharmaceutical Company Information
Table 121. Beijing Four Rings Biopharmaceutical Description and Major Businesses
Table 122. Beijing Four Rings Biopharmaceutical Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Beijing Four Rings Biopharmaceutical Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Beijing Four Rings Biopharmaceutical Recent Developments
Table 125. Jiangsu Kingsley Pharmaceutical Company Information
Table 126. Jiangsu Kingsley Pharmaceutical Description and Major Businesses
Table 127. Jiangsu Kingsley Pharmaceutical Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Jiangsu Kingsley Pharmaceutical Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Jiangsu Kingsley Pharmaceutical Recent Developments
Table 130. Beijing Yuance Pharmaceutical Company Information
Table 131. Beijing Yuance Pharmaceutical Description and Major Businesses
Table 132. Beijing Yuance Pharmaceutical Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Beijing Yuance Pharmaceutical Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Beijing Yuance Pharmaceutical Recent Developments
Table 135. Beijing SL Pharm Company Information
Table 136. Beijing SL Pharm Description and Major Businesses
Table 137. Beijing SL Pharm Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Beijing SL Pharm Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Beijing SL Pharm Recent Developments
Table 140. Shanghai Huaxin Biotechnology Company Information
Table 141. Shanghai Huaxin Biotechnology Description and Major Businesses
Table 142. Shanghai Huaxin Biotechnology Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Shanghai Huaxin Biotechnology Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Shanghai Huaxin Biotechnology Recent Developments
Table 145. Changchun Institute Of Biological Products Company Information
Table 146. Changchun Institute Of Biological Products Description and Major Businesses
Table 147. Changchun Institute Of Biological Products Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Changchun Institute Of Biological Products Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Changchun Institute Of Biological Products Recent Developments
Table 150. Shandong Quangang Pharmaceutical Company Information
Table 151. Shandong Quangang Pharmaceutical Description and Major Businesses
Table 152. Shandong Quangang Pharmaceutical Human Interleukin-2 for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Shandong Quangang Pharmaceutical Human Interleukin-2 for Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Shandong Quangang Pharmaceutical Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Human Interleukin-2 for Injection Distributors List
Table 158. Human Interleukin-2 for Injection Customers List
Table 159. Human Interleukin-2 for Injection Market Trends
Table 160. Human Interleukin-2 for Injection Market Drivers
Table 161. Human Interleukin-2 for Injection Market Challenges
Table 162. Human Interleukin-2 for Injection Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Interleukin-2 for Injection Product Picture
Figure 2. Global Human Interleukin-2 for Injection Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Human Interleukin-2 for Injection Market Share by Type in 2022 & 2029
Figure 4. 50000 IU Product Picture
Figure 5. 100000 IU Product Picture
Figure 6. 200000 IU Product Picture
Figure 7. 500000 IU Product Picture
Figure 8. 1 Million IU Product Picture
Figure 9. Global Human Interleukin-2 for Injection Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Human Interleukin-2 for Injection Market Share by Application in 2022 & 2029
Figure 11. Hospital
Figure 12. Pharmacy
Figure 13. Human Interleukin-2 for Injection Report Years Considered
Figure 14. Global Human Interleukin-2 for Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Human Interleukin-2 for Injection Revenue 2018-2029 (US$ Million)
Figure 16. Global Human Interleukin-2 for Injection Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Human Interleukin-2 for Injection Revenue Market Share by Region (2018-2029)
Figure 18. Global Human Interleukin-2 for Injection Sales 2018-2029 ((K Units)
Figure 19. Global Human Interleukin-2 for Injection Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Human Interleukin-2 for Injection Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Human Interleukin-2 for Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Human Interleukin-2 for Injection Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Human Interleukin-2 for Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Human Interleukin-2 for Injection Sales YoY (2018-2029) & (K Units)
Figure 25. China Human Interleukin-2 for Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Human Interleukin-2 for Injection Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Human Interleukin-2 for Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Human Interleukin-2 for Injection Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Human Interleukin-2 for Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Human Interleukin-2 for Injection in the World: Market Share by Human Interleukin-2 for Injection Revenue in 2022
Figure 32. Global Human Interleukin-2 for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Human Interleukin-2 for Injection Sales Market Share by Type (2018-2029)
Figure 34. Global Human Interleukin-2 for Injection Revenue Market Share by Type (2018-2029)
Figure 35. Global Human Interleukin-2 for Injection Sales Market Share by Application (2018-2029)
Figure 36. Global Human Interleukin-2 for Injection Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Human Interleukin-2 for Injection Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Human Interleukin-2 for Injection Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Human Interleukin-2 for Injection Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Human Interleukin-2 for Injection Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Human Interleukin-2 for Injection Revenue Share by Country (2018-2029)
Figure 42. US & Canada Human Interleukin-2 for Injection Sales Share by Country (2018-2029)
Figure 43. U.S. Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Human Interleukin-2 for Injection Sales Market Share by Type (2018-2029)
Figure 46. Europe Human Interleukin-2 for Injection Revenue Market Share by Type (2018-2029)
Figure 47. Europe Human Interleukin-2 for Injection Sales Market Share by Application (2018-2029)
Figure 48. Europe Human Interleukin-2 for Injection Revenue Market Share by Application (2018-2029)
Figure 49. Europe Human Interleukin-2 for Injection Revenue Share by Country (2018-2029)
Figure 50. Europe Human Interleukin-2 for Injection Sales Share by Country (2018-2029)
Figure 51. Germany Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 52. France Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 56. China Human Interleukin-2 for Injection Sales Market Share by Type (2018-2029)
Figure 57. China Human Interleukin-2 for Injection Revenue Market Share by Type (2018-2029)
Figure 58. China Human Interleukin-2 for Injection Sales Market Share by Application (2018-2029)
Figure 59. China Human Interleukin-2 for Injection Revenue Market Share by Application (2018-2029)
Figure 60. Asia Human Interleukin-2 for Injection Sales Market Share by Type (2018-2029)
Figure 61. Asia Human Interleukin-2 for Injection Revenue Market Share by Type (2018-2029)
Figure 62. Asia Human Interleukin-2 for Injection Sales Market Share by Application (2018-2029)
Figure 63. Asia Human Interleukin-2 for Injection Revenue Market Share by Application (2018-2029)
Figure 64. Asia Human Interleukin-2 for Injection Revenue Share by Region (2018-2029)
Figure 65. Asia Human Interleukin-2 for Injection Sales Share by Region (2018-2029)
Figure 66. Japan Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 70. India Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Human Interleukin-2 for Injection Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Human Interleukin-2 for Injection Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Human Interleukin-2 for Injection Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Human Interleukin-2 for Injection Sales Share by Country (2018-2029)
Figure 77. Brazil Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Human Interleukin-2 for Injection Revenue (2018-2029) & (US$ Million)
Figure 82. Human Interleukin-2 for Injection Value Chain
Figure 83. Human Interleukin-2 for Injection Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed